1 Hofman MS, "[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial" 397 : 797-804, 2021
2 Cheng G, "Superscan-like hypermetabolic lesions on delayed FDG PET/CT imaging in a patient with lung cancer" 37 : 912-913, 2012
3 Sager S, "Superscan Imaging on Ga-68 PSMA PET/CT in prostate cancer patient" 8 : 1-, 2017
4 Dias AH, "Skeletal "Superscan" on 18F-choline PET/CT: cases of myeloproliferative disease" 41 : 173-174, 2016
5 Mokoala K, "PSMA theranostics : science and practice" 13 : 3904-, 2021
6 김대응 ; 김창근 ; 박순아 ; 정상아 ; 양세훈, "Metabolic Super Scan in 18F-FDG PET/CT Imaging" 대한의학회 25 (25): 1256-1257, 2010
7 Su HY, "F-18 FDG PET superscan" 31 : 28-29, 2006
8 Bailly M, "18FFDG PET/CT superscan in prostate cancer" 39 : 912-914, 2014
1 Hofman MS, "[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial" 397 : 797-804, 2021
2 Cheng G, "Superscan-like hypermetabolic lesions on delayed FDG PET/CT imaging in a patient with lung cancer" 37 : 912-913, 2012
3 Sager S, "Superscan Imaging on Ga-68 PSMA PET/CT in prostate cancer patient" 8 : 1-, 2017
4 Dias AH, "Skeletal "Superscan" on 18F-choline PET/CT: cases of myeloproliferative disease" 41 : 173-174, 2016
5 Mokoala K, "PSMA theranostics : science and practice" 13 : 3904-, 2021
6 김대응 ; 김창근 ; 박순아 ; 정상아 ; 양세훈, "Metabolic Super Scan in 18F-FDG PET/CT Imaging" 대한의학회 25 (25): 1256-1257, 2010
7 Su HY, "F-18 FDG PET superscan" 31 : 28-29, 2006
8 Bailly M, "18FFDG PET/CT superscan in prostate cancer" 39 : 912-914, 2014